OCTAPLEX
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
Identification
- Active ingredient (INN)
- COMPLEXE HUMAIN PLASMATIQUE PROTHROMBINIQUE
- Internal code
- 12 J 191
- Country of Origin
- Austria
- Pharmaceutical form
- Powder + Solvent for Perfusion Sol.
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01 flacon de pdre + 01 flacon de solv de 20ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Acute bleeding, with patients in need of surgery.
Associated Conditions
Some have suffered from the complications of IVC, so good medical monitoring of signs and symptoms is required.
Pneumococcal systolic patients, unstable bra butchers, and ocean vascular diseases.
Patients receiving
VKA are willing to undergo the phosphone design, so caution must be taken and the potential benefits balanced against risks should reflect the effect of vitamin K antigens after receiving a compound human prothrombin.
Mechanism of Action
An Intravenous solution from a complex human prothrombin, which is used to reverse the effects of the lack of vitamin K clotting agent (such as the use of Warfarin), and patients with severe bleeding or in need of urgent surgery.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina, prepare the answer for you.